top of page
News & Updates
Join us at JPM2025 (Jan 2025)
We’re excited to attend JPM 2025 and share updates on our pioneering chemistry platform. Our latest data from the ALS program will also be available for discussion.
Let’s connect to explore investment or partnership opportunities, whether you’re familiar with our work or learning about us for the first time. We look forward to engaging with fellow innovators and advancing collaborations that drive impact.
Let’s connect to explore investment or partnership opportunities, whether you’re familiar with our work or learning about us for the first time. We look forward to engaging with fellow innovators and advancing collaborations that drive impact.
Ilios Therapeutics Presents at LabCentral's Inaugural Mind Matters Scientific Symposium (Nov 2024)
Ilios Therapeutics was honored to present a poster at LabCentral's inaugural Mind Matters Scientific Symposium, which brought together leading experts to discuss advancements in neurodegenerative disease research from clinical, preclinical, and investment perspectives.
We extend our gratitude to LabCentral, especially Johannes Fruehauf and Sezin Yigit, PhD, for organizing this impactful event, and to all participants for their invaluable insights.
We extend our gratitude to LabCentral, especially Johannes Fruehauf and Sezin Yigit, PhD, for organizing this impactful event, and to all participants for their invaluable insights.
SCBio Showcases Ilios as a MassBio Success (Nov 2024)
Ilios was honored to be showcased by SCBio as an example of innovation emerging from the MassBio ecosystem during an event in Charleston, South Carolina, just before Thanksgiving. The opportunity to highlight our work in developing multi-functional therapeutics for neurodegenerative diseases underscores the importance of a strong, supportive biotech community.
We extend our gratitude to Kendalle O'Connell, James Chappell, and the event organizers for their leadership and support. Thanks to the ecosystem for helping advance our mission of tackling complex diseases with innovative solutions.
We extend our gratitude to Kendalle O'Connell, James Chappell, and the event organizers for their leadership and support. Thanks to the ecosystem for helping advance our mission of tackling complex diseases with innovative solutions.
Ilios participates to the inaugural workshop for Project Mosaic (Nov 2024)
Ilios joined the inaugural workshop for Project Mosaic, an initiative focused on developing robust and translatable models for sporadic ALS. Held in Washington, DC, the event brought together drug makers, CROs, academic researchers, nonprofits, and government leaders to discuss priorities like genetically representative models, TDP-43 mislocalization, and cell survival as key phenotypes for advancing ALS research.
We thank Bernie Zipprich and the Project Mosaic team for their exceptional leadership and commitment to collaboration. Bernie, your resilience inspires us to drive impactful research. Ilios is excited to continue supporting this initiative and contributing to solutions that bring us closer to meaningful progress in ALS.
We thank Bernie Zipprich and the Project Mosaic team for their exceptional leadership and commitment to collaboration. Bernie, your resilience inspires us to drive impactful research. Ilios is excited to continue supporting this initiative and contributing to solutions that bring us closer to meaningful progress in ALS.
Ilios wins the Boston Biotech PitchFest (Nov 2024)
Ilios was selected as one of the three winners for the 2024 edition of the Boston PitchFest hosted by Portal Innovations.
Over 80 innovative biotech spartups participated in a fun eveneing of elevator pitches culminating in a few full presentations.
Over 80 innovative biotech spartups participated in a fun eveneing of elevator pitches culminating in a few full presentations.
bottom of page